Skip to main content
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases 1/2019

15.10.2018 | Original Article

Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis

verfasst von: David Chirio, Marion Le Marechal, Pamela Moceri, Arnaud de la Chapelle, Sylvie Chaillou-Optiz, Anaïs Mothes, Cédric Foucault, Laurence Maulin, Chirine Parsaï, Pierre-Marie Roger, Elisa Demonchy

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

We aimed to identify factors associated with unfavorable outcome in patients treated for infective endocarditis (IE), with a focus on departure from European guidelines. We conducted a retrospective audit of all adult patients treated for endocarditis during a 1-year period across a regional network of nine care centers in the south-east of France. Medical records were reviewed regarding patient and infection characteristics, antibiotic therapy, outcome, and compliance to the European Society of Cardiology guidelines. Antibiotic treatment appropriateness was evaluated regarding molecule, dosage, and duration, according to guidelines. Primary endpoint was the assessment of factors associated with unfavorable outcome, defined as in-hospital mortality or IE relapse at 1-year follow-up. Secondary endpoints were intensive care admission, iatrogenic events, and nosocomial infections that occurred during hospital stay. One hundred patients were included. Median age was 71 years old. Twenty-two patients died and IE relapse occurred in two patients, representing 24 patients with unfavorable outcome. Overall, antibiotic treatment was deemed appropriate in 28 cases. Thirty-three patients required intensive care, 34 iatrogenic events were found, including 19 acute kidney injuries, and 13 nosocomial infections occurred during care. Using a logistic regression, factors associated with unfavorable outcome were admission in the intensive care unit (adjusted odd ratio 7.26 [1.8–29.28]; p = 0.005), new-onset nosocomial infection (adjusted odd ratio 8.83 [1.42–54.6]; p = 0.019), and age > 71 years old (adjusted odd ratio 11.2 [2.76–46.17]; p < 0.001). Departure from guidelines was frequent but not related to unfavorable outcome in our study. Only intensive care, age, and nosocomial infections were associated with mortality and relapse. Iatrogenic events were numerous, with no impact on outcome.
Literatur
1.
Zurück zum Zitat Abdulhak AAB, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA et al (2014) Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart 9:131–143CrossRef Abdulhak AAB, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA et al (2014) Global and regional burden of infective endocarditis, 1990–2010: a systematic review of the literature. Glob Heart 9:131–143CrossRef
2.
Zurück zum Zitat Ambrosioni J, Hernandez-Meneses M, Téllez A, Pericàs J, Falces C, Tolosana J et al (2017) The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep 19:1–10CrossRef Ambrosioni J, Hernandez-Meneses M, Téllez A, Pericàs J, Falces C, Tolosana J et al (2017) The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep 19:1–10CrossRef
3.
Zurück zum Zitat Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F et al (2017) Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther 7:27–35CrossRefPubMedPubMedCentral Cresti A, Chiavarelli M, Scalese M, Nencioni C, Valentini S, Guerrini F et al (2017) Epidemiological and mortality trends in infective endocarditis, a 17-year population-based prospective study. Cardiovasc Diagn Ther 7:27–35CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Chirillo F, Scotton P, Rocco F, Rigoli R, Borsatto F, Pedrocco A et al (2013) Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol 112:1171–1176CrossRefPubMed Chirillo F, Scotton P, Rocco F, Rigoli R, Borsatto F, Pedrocco A et al (2013) Impact of a multidisciplinary management strategy on the outcome of patients with native valve infective endocarditis. Am J Cardiol 112:1171–1176CrossRefPubMed
5.
Zurück zum Zitat Lagier J-C, Aubry C, Delord M, Michelet P, Tissot-Dupont H, Million M et al (2017) From expert protocols to standardized management of infectious diseases. Clin Infect Dis 65:S12–S19CrossRefPubMed Lagier J-C, Aubry C, Delord M, Michelet P, Tissot-Dupont H, Million M et al (2017) From expert protocols to standardized management of infectious diseases. Clin Infect Dis 65:S12–S19CrossRefPubMed
6.
Zurück zum Zitat Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30:2369–2413CrossRefPubMed Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I et al (2009) Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 30:2369–2413CrossRefPubMed
7.
Zurück zum Zitat Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 36:3075–3128CrossRefPubMed Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F et al (2015) 2015 ESC guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Eur Heart J 36:3075–3128CrossRefPubMed
8.
Zurück zum Zitat Tissot-Dupont H, Casalta JP, Gouriet F, Hubert S, Salaun E, Habib G et al (2017) International experts’ practice in the antibiotic therapy of infective endocarditis is not following the guidelines. Clin Microbiol Infect 23:736–739CrossRefPubMed Tissot-Dupont H, Casalta JP, Gouriet F, Hubert S, Salaun E, Habib G et al (2017) International experts’ practice in the antibiotic therapy of infective endocarditis is not following the guidelines. Clin Microbiol Infect 23:736–739CrossRefPubMed
9.
Zurück zum Zitat Béraud G, Pulcini C, Paño-Pardo JR, Hoen B, Beovic B, Nathwani D (2016) How do physicians cope with controversial topics in existing guidelines for the management of infective endocarditis? Results of an international survey. Clin Microbiol Infect 22:163–170CrossRefPubMed Béraud G, Pulcini C, Paño-Pardo JR, Hoen B, Beovic B, Nathwani D (2016) How do physicians cope with controversial topics in existing guidelines for the management of infective endocarditis? Results of an international survey. Clin Microbiol Infect 22:163–170CrossRefPubMed
10.
Zurück zum Zitat Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A et al (2015) Trends in infective endocarditis: incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 65:2070–2076CrossRefPubMed Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A et al (2015) Trends in infective endocarditis: incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol 65:2070–2076CrossRefPubMed
11.
Zurück zum Zitat Gonzalez de Molina M, Fernández-Guerrero JC, Azpitarte J (2002) Infectious endocarditis: degree of discordance between clinical guidelines recommendations and clinical practice. Rev Esp Cardiol 55:793–800CrossRefPubMed Gonzalez de Molina M, Fernández-Guerrero JC, Azpitarte J (2002) Infectious endocarditis: degree of discordance between clinical guidelines recommendations and clinical practice. Rev Esp Cardiol 55:793–800CrossRefPubMed
12.
Zurück zum Zitat Demonchy E, Dellamonica P, Roger PM, Bernard E, Cua E, Pulcini C (2011) Audit of antibiotic therapy used in 66 cases of endocarditis. Méd Mal Infect 41:602–607CrossRefPubMed Demonchy E, Dellamonica P, Roger PM, Bernard E, Cua E, Pulcini C (2011) Audit of antibiotic therapy used in 66 cases of endocarditis. Méd Mal Infect 41:602–607CrossRefPubMed
13.
Zurück zum Zitat Di Mauro M, Dato GMA, Barili F, Gelsomino S, Santè P, Corte AD et al (2017) A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis: the EndoSCORE. Int J Cardiol 241:97–102CrossRefPubMed Di Mauro M, Dato GMA, Barili F, Gelsomino S, Santè P, Corte AD et al (2017) A predictive model for early mortality after surgical treatment of heart valve or prosthesis infective endocarditis: the EndoSCORE. Int J Cardiol 241:97–102CrossRefPubMed
14.
Zurück zum Zitat Subbaraju P, Rai S, Morakhia J, Midha G, Kamath A, Saravu K (2018) Clinical – microbiological characterization and risk factors of mortality in infective endocarditis from a tertiary care academic hospital in Southern India. Indian Heart J 70:259–265CrossRefPubMed Subbaraju P, Rai S, Morakhia J, Midha G, Kamath A, Saravu K (2018) Clinical – microbiological characterization and risk factors of mortality in infective endocarditis from a tertiary care academic hospital in Southern India. Indian Heart J 70:259–265CrossRefPubMed
15.
Zurück zum Zitat Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V et al (2016) Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37:840–848CrossRefPubMed Iung B, Doco-Lecompte T, Chocron S, Strady C, Delahaye F, Le Moing V et al (2016) Cardiac surgery during the acute phase of infective endocarditis: discrepancies between European Society of Cardiology guidelines and practices. Eur Heart J 37:840–848CrossRefPubMed
16.
Zurück zum Zitat Ibrahim SL, Zhang L, Brady TM, Hsu AJ, Cosgrove SE, Tamma PD (2015) Low-dose gentamicin for uncomplicated Enterococcus faecalis bacteremia may be nephrotoxic in children. Clin Infect Dis 61:1119–1124CrossRefPubMedPubMedCentral Ibrahim SL, Zhang L, Brady TM, Hsu AJ, Cosgrove SE, Tamma PD (2015) Low-dose gentamicin for uncomplicated Enterococcus faecalis bacteremia may be nephrotoxic in children. Clin Infect Dis 61:1119–1124CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Ritchie BM, Hirning BA, Stevens CA, Cohen SA, DeGrado JR (2017) Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center. J Chemother 29:292–298CrossRefPubMed Ritchie BM, Hirning BA, Stevens CA, Cohen SA, DeGrado JR (2017) Risk factors for acute kidney injury associated with the treatment of bacterial endocarditis at a tertiary academic medical center. J Chemother 29:292–298CrossRefPubMed
Metadaten
Titel
Factors associated with unfavorable outcome in a multicenter audit of 100 infective endocarditis
verfasst von
David Chirio
Marion Le Marechal
Pamela Moceri
Arnaud de la Chapelle
Sylvie Chaillou-Optiz
Anaïs Mothes
Cédric Foucault
Laurence Maulin
Chirine Parsaï
Pierre-Marie Roger
Elisa Demonchy
Publikationsdatum
15.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 1/2019
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-018-3401-9

Weitere Artikel der Ausgabe 1/2019

European Journal of Clinical Microbiology & Infectious Diseases 1/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.